mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.5 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.5 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.5 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |